Traveler's diarrhea: updates for pediatricians

Jocelyn Y Ang1, Ambika Mathur

  • 1Carman and Ann Adams Department of Pediatrics, Wayne State University , Detroit, MI 48201, USA.

Pediatric Annals
|January 16, 2009
PubMed

Insights

Traveler's diarrhea (TD) in children requires detailed pre-travel counseling on prevention and management. Oral rehydration solutions are key for mild cases, while antibiotics like azithromycin may be used for moderate to severe TD in children.

Area of Science:

  • Pediatric Travel Medicine
  • Infectious Diseases
  • Public Health

Background:

  • Children are susceptible to traveler's diarrhea (TD), similar to adults.
  • The specific risks, causes, and treatments for TD in children are not well-established.
  • Pre-travel consultations are crucial for addressing TD in pediatric travelers.

Purpose of the Study:

  • To define the risks and management strategies for traveler's diarrhea in children.
  • To emphasize the importance of pre-travel counseling for pediatric TD prevention and self-treatment.
  • To provide guidance on medication use and potential adverse effects for children with TD.

Main Methods:

  • Review of existing literature on pediatric traveler's diarrhea.
  • Analysis of treatment protocols for mild, moderate, and severe TD in children.
  • Guidelines for the use of oral rehydration solutions (ORS) and antibiotics (e.g., azithromycin).

Main Results:

  • Mild TD in children can be effectively managed with oral rehydration solutions.
  • Azithromycin may be considered for moderate to severe TD in pediatric travelers.
  • Caregivers must monitor for improvement, especially after antibiotic self-treatment.

Conclusions:

  • Comprehensive pre-travel education is essential for preventing and managing TD in children.
  • Appropriate use of ORS and timely antibiotic intervention are critical for pediatric TD.
  • Consultation with local health authorities is advised if symptoms persist.

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Giardiasis01:12

Giardiasis

Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...